A synthetic peptide for use as a blocking control in assays to test for specificity of MYH9 antibody, Alternative Names: MYH9 control peptide, MYH9 antibody Blocking Peptide, Anti-MYH9 Blocking Peptide, Myosin Heavy Chain 9 Non-Muscle Blocking Peptide, DFNA17 Blocking Peptide, EPSTS Blocking Peptide, FTNS Blocking Peptide, MGC104539 Blocking Peptide, MHA Blocking Peptide, NMHC-II-A Blocking Peptide, NMMHCA Blocking Peptide, MYH9, MYH-9, MYH 9, MYH-9 Blocking Peptide, MYH 9 Blocking Peptide
Purification
Rabbit Anti-EGFR (Phospho-Tyr1197) Polyclonal Antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
MYH9 is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.